{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T08:27:05Z","timestamp":1793694425730,"version":"4.5.1"},"reference-count":68,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2018,7,23]],"date-time":"2018-07-23T00:00:00Z","timestamp":1532304000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Med"],"published-print":{"date-parts":[[2018,9]]},"DOI":"10.1038\/s41591-018-0125-4","type":"journal-article","created":{"date-parts":[[2018,7,19]],"date-time":"2018-07-19T06:05:51Z","timestamp":1531980351000},"page":"1384-1394","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":273,"title":["Metformin inhibits gluconeogenesis via a redox-dependent mechanism in vivo"],"prefix":"10.1038","volume":"24","author":[{"given":"Anila K.","family":"Madiraju","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yang","family":"Qiu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rachel J.","family":"Perry","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasmeen","family":"Rahimi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xian-Man","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dongyan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jo\u00e3o-Paulo G.","family":"Camporez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gary W.","family":"Cline","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gina M.","family":"Butrico","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6735-5082","authenticated-orcid":false,"given":"Bruce E.","family":"Kemp","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gregori","family":"Casals","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gregory R.","family":"Steinberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel F.","family":"Vatner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kitt F.","family":"Petersen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1529-5668","authenticated-orcid":false,"given":"Gerald I.","family":"Shulman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,7,23]]},"reference":[{"key":"125_CR1","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1042\/bj3480607","volume":"348","author":"MR Owen","year":"2000","unstructured":"Owen, M. R., Doran, E. & Halestrap, A. P. Evidence that metformin exerts its anti-diabetic effects through inhibition of complex 1 of the mitochondrial respiratory chain. Biochem. J. 348, 607\u2013614 (2000).","journal-title":"Biochem. J."},{"key":"125_CR2","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1074\/jbc.275.1.223","volume":"275","author":"MY El-Mir","year":"2000","unstructured":"El-Mir, M.-Y. et al. Dimethylbiguanide inhibits cell respiration via an indirect effect targeted on the respiratory chain complex I. J. Biol. Chem. 275, 223\u2013228 (2000).","journal-title":"J. Biol. Chem."},{"key":"125_CR3","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1016\/j.cell.2009.03.016","volume":"137","author":"L He","year":"2009","unstructured":"He, L. et al. Metformin and insulin suppress hepatic gluconeogenesis through phosphorylation of CREB binding protein. Cell 137, 635\u2013646 (2009).","journal-title":"Cell"},{"key":"125_CR4","doi-asserted-by":"publisher","first-page":"20435","DOI":"10.1074\/jbc.M114.567271","volume":"289","author":"J Cao","year":"2014","unstructured":"Cao, J. et al. Low concentrations of metformin suppress glucose production in hepatocytes through AMP-activated protein kinase (AMPK). J. Biol. Chem. 289, 20435\u201320446 (2014).","journal-title":"J. Biol. Chem."},{"key":"125_CR5","doi-asserted-by":"publisher","first-page":"1649","DOI":"10.1038\/nm.3372","volume":"19","author":"MD Fullerton","year":"2013","unstructured":"Fullerton, M. D. et al. Single phosphorylation sites in Acc1 and Acc2 regulate lipid homeostasis and the insulin-sensitizing effects of metformin. Nat. Med. 19, 1649\u20131654 (2013).","journal-title":"Nat. Med."},{"key":"125_CR6","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1016\/j.cmet.2006.05.005","volume":"3","author":"B Cool","year":"2006","unstructured":"Cool, B. et al. Identification and characterization of a small molecule AMPK activator that treats key components of type 2 diabetes and the metabolic syndrome. Cell Metab. 3, 403\u2013416 (2006).","journal-title":"Cell Metab."},{"key":"125_CR7","first-page":"327","volume":"107","author":"B Guigas","year":"2016","unstructured":"Guigas, B. & Viollet, B. Targeting AMPK: from ancient drugs to new small-molecule activators. EXS 107, 327\u2013350 (2016).","journal-title":"EXS"},{"key":"125_CR8","doi-asserted-by":"publisher","first-page":"1577","DOI":"10.1007\/s00125-017-4342-z","volume":"60","author":"G Rena","year":"2017","unstructured":"Rena, G., Hardie, D. G. & Pearson, E. R. The mechanisms of action of metformin. Diabetologia 60, 1577\u20131585 (2017).","journal-title":"Diabetologia"},{"key":"125_CR9","doi-asserted-by":"publisher","first-page":"1642","DOI":"10.1126\/science.1120781","volume":"310","author":"RJ Shaw","year":"2005","unstructured":"Shaw, R. J. et al. The kinase LKB1 mediates glucose homeostasis in liver and therapeutic effects of metformin. Science 310, 1642\u20131646 (2005).","journal-title":"Science"},{"key":"125_CR10","doi-asserted-by":"publisher","first-page":"E730","DOI":"10.1152\/ajpendo.00225.2016","volume":"311","author":"BK Smith","year":"2016","unstructured":"Smith, B. K. et al. Treatment of nonalcoholic fatty liver disease: role of AMPK. Am. J. Physiol. Endocrinol. Metab. 311, E730\u2013E740 (2016).","journal-title":"Am. J. Physiol. Endocrinol. Metab."},{"key":"125_CR11","doi-asserted-by":"publisher","first-page":"2355","DOI":"10.1172\/JCI40671","volume":"120","author":"M Foretz","year":"2010","unstructured":"Foretz, M. et al. Metformin inhibits hepatic gluconeogenesis in mice independently of the LKB1\/AMPK pathway via a decrease in hepatic energy state. J. Clin. Invest. 120, 2355\u20132369 (2010).","journal-title":"J. Clin. Invest."},{"key":"125_CR12","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1038\/nature11808","volume":"494","author":"RA Miller","year":"2013","unstructured":"Miller, R. A. et al. Biguanides suppress hepatic glucagon signalling by decreasing production of cyclic AMP. Nature 494, 256\u2013260 (2013).","journal-title":"Nature"},{"key":"125_CR13","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms10856","volume":"7","author":"M Johanns","year":"2016","unstructured":"Johanns, M. et al. AMPK antagonizes hepatic glucagon-stimulated cyclic AMP signalling via phosphorylation-induced activation of cyclic nucleotide phosphodiesterase 4B. Nat. Commun. 7, 10856 (2016).","journal-title":"Nat. Commun."},{"key":"125_CR14","doi-asserted-by":"publisher","first-page":"2420","DOI":"10.2337\/diabetes.51.8.2420","volume":"51","author":"SA Hawley","year":"2002","unstructured":"Hawley, S. A., Gadalla, A. E., Olsen, G. S. & Hardie, D. G. The antidiabetic drug metformin activates the AMP-activated protein kinase cascade via an adenine nucleotide-independent mechanism. Diabetes 51, 2420\u20132425 (2002).","journal-title":"Diabetes"},{"key":"125_CR15","doi-asserted-by":"publisher","first-page":"542","DOI":"10.1038\/nature13270","volume":"510","author":"AK Madiraju","year":"2014","unstructured":"Madiraju, A. K. et al. Metformin suppresses gluconeogenesis by inhibiting mitochondrial glycerophosphate dehydrogenase. Nature 510, 542\u2013546 (2014).","journal-title":"Nature"},{"key":"125_CR16","doi-asserted-by":"publisher","first-page":"763","DOI":"10.1016\/0003-9861(73)90571-7","volume":"158","author":"AI Cederbaum","year":"1973","unstructured":"Cederbaum, A. I., Lieber, C. S., Beattie, D. S. & Rubin, E. Characterization of shuttle mechanisms for the transport of reducing equivalents into mitochondria. Arch. Biochem. Biophys. 158, 763\u2013781 (1973).","journal-title":"Arch. Biochem. Biophys."},{"key":"125_CR17","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1038\/9667","volume":"22","author":"K Kobayashi","year":"1999","unstructured":"Kobayashi, K. et al. The gene mutated in adult-onset type II citrullinaemia encodes a putative mitochondrial carrier protein. Nat. Genet. 22, 159\u2013163 (1999).","journal-title":"Nat. Genet."},{"key":"125_CR18","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1016\/0026-0495(71)90087-4","volume":"20","author":"KF LaNoue","year":"1971","unstructured":"LaNoue, K. F. & Williamson, J. R. Interrelationships between malate\u2013aspartate shuttle and citric acid cycle in rat heart mitochondria. Metabolism 20, 119\u2013140 (1971).","journal-title":"Metabolism"},{"key":"125_CR19","doi-asserted-by":"crossref","first-page":"8978","DOI":"10.1016\/S0021-9258(19)40681-9","volume":"250","author":"M Jomain-Baum","year":"1975","unstructured":"Jomain-Baum, M. & Hanson, R. W. Regulation of hepatic gluconeogenesis in the guinea pig by fatty acids and ammonia. J. Biol. Chem. 250, 8978\u20138985 (1975).","journal-title":"J. Biol. Chem."},{"key":"125_CR20","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1093\/oxfordjournals.jbchem.a132721","volume":"87","author":"T Sugano","year":"1980","unstructured":"Sugano, T. et al. Intracellular redox state and stimulation of gluconeogenesis by glucagon and norepinephrine in the perfused rat liver. J. Biochem. 87, 153\u2013166 (1980).","journal-title":"J. Biochem."},{"key":"125_CR21","doi-asserted-by":"crossref","first-page":"4617","DOI":"10.1016\/S0021-9258(18)93669-0","volume":"244","author":"JR Williamson","year":"1969","unstructured":"Williamson, J. R., Scholz, R. & Browning, E. T. Control mechanisms of gluconeogenesis and ketogenesis. II Interactions between fatty acid oxidation and the citric acid cycle in perfused rat liver.J. Biol. Chem 244, 4617\u20134627 (1969).","journal-title":"J. Biol. Chem"},{"key":"125_CR22","doi-asserted-by":"crossref","first-page":"5044","DOI":"10.1016\/S0021-9258(18)94307-3","volume":"244","author":"JR Williamson","year":"1969","unstructured":"Williamson, J. R., Scholz, R., Browning, E. T., Thurman, R. G. & Fukami, M. H. Metabolic effects of ethanol in perfused rat liver. J. Biol. Chem. 244, 5044\u20135054 (1969).","journal-title":"J. Biol. Chem."},{"key":"125_CR23","doi-asserted-by":"publisher","first-page":"745","DOI":"10.1016\/j.cell.2015.01.012","volume":"160","author":"RJ Perry","year":"2015","unstructured":"Perry, R. J. et al. Hepatic acetyl CoA links adipose tissue inflammation to hepatic insulin resistance and type 2 diabetes. Cell 160, 745\u2013758 (2015).","journal-title":"Cell"},{"key":"125_CR24","doi-asserted-by":"publisher","first-page":"759","DOI":"10.1038\/nm.3579","volume":"20","author":"RJ Perry","year":"2014","unstructured":"Perry, R. J. et al. Leptin reverses diabetes by suppression of the hypothalamic\u2013pituitary\u2013adrenal axis. Nat. Med. 20, 759\u2013763 (2014).","journal-title":"Nat. Med."},{"key":"125_CR25","doi-asserted-by":"crossref","first-page":"12748","DOI":"10.1016\/S0021-9258(17)38940-8","volume":"260","author":"FD Sistare","year":"1985","unstructured":"Sistare, F. D. & Haynes, R. C.Jr. The interaction between the cytosolic pyridine nucleotide redox potential and gluconeogenesis from lactate\/pyruvate in isolated rat hepatocytes. Implications for investigations of hormone action.J. Biol. Chem. 260, 12748\u201312753 (1985).","journal-title":"J. Biol. Chem."},{"key":"125_CR26","unstructured":"Goodman, L. S. Goodman & Gilman's The Pharmacological Basis of Therapeutics, 12th edn (eds Brunton, L. L., Chabner, B. & Knollmann, B. C.) 1906\u20132000 (McGraw-Hill, New York, 2011)."},{"key":"125_CR27","doi-asserted-by":"publisher","first-page":"506","DOI":"10.1038\/nm.3787","volume":"21","author":"FA Duca","year":"2015","unstructured":"Duca, F. A. et al. Metformin activates a duodenal Ampk-dependent pathway to lower hepatic glucose production in rats. Nat. Med. 21, 506\u2013511 (2015).","journal-title":"Nat. Med."},{"key":"125_CR28","doi-asserted-by":"publisher","first-page":"865","DOI":"10.2337\/diabetes.55.04.06.db05-1178","volume":"55","author":"B Guigas","year":"2006","unstructured":"Guigas, B. et al. 5-Aminoimidazole-4-carboxamide-1-\u03b2-d-ribofuranoside and metformin inhibit hepatic glucose phosphorylation by an AMP-activated protein kinase-independent effect on glucokinase translocation. Diabetes 55, 865\u2013874 (2006).","journal-title":"Diabetes"},{"key":"125_CR29","doi-asserted-by":"publisher","first-page":"1167","DOI":"10.1172\/JCI13505","volume":"108","author":"G Zhou","year":"2001","unstructured":"Zhou, G. et al. Role of AMP-activated protein kinase in mechanism of metformin action. J. Clin. Invest. 108, 1167\u20131174 (2001).","journal-title":"J. Clin. Invest."},{"key":"125_CR30","doi-asserted-by":"publisher","first-page":"2063","DOI":"10.2337\/diabetes.49.12.2063","volume":"49","author":"RS Hundal","year":"2000","unstructured":"Hundal, R. S. et al. Mechanism by which metformin reduces glucose production in type 2 diabetes. Diabetes 49, 2063\u20132069 (2000).","journal-title":"Diabetes"},{"key":"125_CR31","doi-asserted-by":"publisher","first-page":"867","DOI":"10.1056\/NEJM199803263381303","volume":"338","author":"SE Inzucchi","year":"1998","unstructured":"Inzucchi, S. E. et al. Efficacy and metabolic effects of metformin and troglitazone in type II diabetes mellitus. N. Engl. J. Med. 338, 867\u2013872 (1998).","journal-title":"N. Engl. J. Med."},{"key":"125_CR32","doi-asserted-by":"publisher","first-page":"1619","DOI":"10.1053\/meta.2000.18561","volume":"49","author":"CA Chu","year":"2000","unstructured":"Chu, C. A. et al. The acute effect of metformin on glucose production in the conscious dog is primarily attributable to inhibition of glycogenolysis. Metabolism 49, 1619\u20131626 (2000).","journal-title":"Metabolism"},{"key":"125_CR33","doi-asserted-by":"publisher","first-page":"139","DOI":"10.2337\/diabetes.51.1.139","volume":"51","author":"G Mithieux","year":"2002","unstructured":"Mithieux, G., Guignot, L., Bordet, J. C. & Wiernsperger, N. Intrahepatic mechanisms underlying the effect of metformin in decreasing basal glucose production in rats fed a high-fat diet. Diabetes 51, 139\u2013143 (2002).","journal-title":"Diabetes"},{"key":"125_CR34","doi-asserted-by":"publisher","first-page":"1659","DOI":"10.1001\/jama.2011.520","volume":"305","author":"JE Lavine","year":"2011","unstructured":"Lavine, J. E. et al. Effect of vitamin E or metformin for treatment of nonalcoholic fatty liver disease in children and adolescents: the TONIC randomized controlled trial. J. Am. Med. Assoc. 305, 1659\u20131668 (2011).","journal-title":"J. Am. Med. Assoc."},{"key":"125_CR35","doi-asserted-by":"publisher","first-page":"1211","DOI":"10.1111\/j.1365-2036.2010.04467.x","volume":"32","author":"MO Rakoski","year":"2010","unstructured":"Rakoski, M. O., Singal, A. G., Rogers, M. A. & Conjeevaram, H. Meta-analysis: insulin sensitizers for the treatment of non-alcoholic steatohepatitis. Aliment. Pharmacol. Ther. 32, 1211\u20131221 (2010).","journal-title":"Aliment. Pharmacol. Ther."},{"key":"125_CR36","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1177\/1756283X09105462","volume":"2","author":"WW Shields","year":"2009","unstructured":"Shields, W. W., Thompson, K. E., Grice, G. A., Harrison, S. A. & Coyle, W. J. The effect of metformin and standard therapy versus standard therapy alone in nondiabetic patients with insulin resistance and nonalcoholic steatohepatitis (NASH): a pilot trial. Ther. Adv. Gastroenterol. 2, 157\u2013163 (2009).","journal-title":"Ther. Adv. Gastroenterol."},{"key":"125_CR37","doi-asserted-by":"publisher","unstructured":"Gormsen, L. C. et al. Metformin does not affect postabsorptive hepatic free fatty acid uptake, oxidation or resecretion in humans: a 3-month placebo-controlled clinical trial in patients with type 2 diabetes and healthy controls. Diabetes Obes. Metab. https:\/\/doi.org\/10.1111\/dom.13244 (2018).","DOI":"10.1111\/dom.13244"},{"key":"125_CR38","doi-asserted-by":"publisher","first-page":"877","DOI":"10.1042\/bj2320877","volume":"232","author":"PR Ryle","year":"1985","unstructured":"Ryle, P. R., Chakraborty, J. & Thomson, A. D. The effect of methylene blue on the hepatocellular redox state and liver lipid content during chronic ethanol feeding in the rat. Biochem. J. 232, 877\u2013882 (1985).","journal-title":"Biochem. J."},{"key":"125_CR39","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1016\/j.cmet.2014.07.013","volume":"20","author":"JA Baur","year":"2014","unstructured":"Baur, J. A. & Birnbaum, M. J. Control of gluconeogenesis by metformin: does redox trump energy charge? Cell Metab. 20, 197\u2013199 (2014).","journal-title":"Cell Metab."},{"key":"125_CR40","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1016\/j.cmet.2015.01.003","volume":"21","author":"L He","year":"2015","unstructured":"He, L. & Wondisford, F. E. Metformin action: concentrations matter. Cell Metab. 21, 159\u2013162 (2015).","journal-title":"Cell Metab."},{"key":"125_CR41","first-page":"789","volume":"75","author":"I Puhakainen","year":"1992","unstructured":"Puhakainen, I., Koivisto, V. A. & Yki-J\u00e4rvinen, H. Lipolysis and gluconeogenesis from glycerol are increased in patients with noninsulin-dependent diabetes mellitus. J. Clin. Endocrinol. Metab. 75, 789\u2013794 (1992).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"125_CR42","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1172\/JCI115558","volume":"89","author":"N Nurjhan","year":"1992","unstructured":"Nurjhan, N., Consoli, A. & Gerich, J. Increased lipolysis and its consequences on gluconeogenesis in non-insulin-dependent diabetes mellitus. J. Clin. Invest. 89, 169\u2013175 (1992).","journal-title":"J. Clin. Invest."},{"key":"125_CR43","doi-asserted-by":"publisher","first-page":"850","DOI":"10.1038\/nm.4345","volume":"23","author":"H Wu","year":"2017","unstructured":"Wu, H. et al. Metformin alters the gut microbiome of individuals with treatment-naive type 2 diabetes, contributing to the therapeutic effects of the drug. Nat. Med. 23, 850\u2013858 (2017).","journal-title":"Nat. Med."},{"key":"125_CR44","first-page":"5","volume":"5","author":"JL Schlienger","year":"1979","unstructured":"Schlienger, J. L., Frick, A., Marbach, J., Freund, H. & Imler, M. Effects of biguanides on the intermediate metabolism of glucose in normal and portal-strictured rats. Diabete Metab. 5, 5\u20139 (1979).","journal-title":"Diabete Metab."},{"key":"125_CR45","doi-asserted-by":"publisher","first-page":"1920","DOI":"10.2967\/jnumed.116.177774","volume":"57","author":"LC Gormsen","year":"2016","unstructured":"Gormsen, L. C. et al. In vivo imaging of human 11C-metformin in peripheral organs: dosimetry, biodistribution, and kinetic analyses. J. Nucl. Med. 57, 1920\u20131926 (2016).","journal-title":"J. Nucl. Med."},{"key":"125_CR46","doi-asserted-by":"crossref","unstructured":"Br\u00f8nden, A. A. A., et al Single-dose metformin enhances bile acid\u2013induced GLP-1 secretion in patients with type 2 diabetes. J. Clin. Endocrinol. Metab. (in the press) (2017).","DOI":"10.1210\/jc.2017-01091"},{"key":"125_CR47","doi-asserted-by":"publisher","first-page":"721","DOI":"10.2165\/00003088-200544070-00004","volume":"44","author":"P Timmins","year":"2005","unstructured":"Timmins, P., Donahue, S., Meeker, J. & Marathe, P. Steady-state pharmacokinetics of a novel extended-release metformin formulation. Clin. Pharmacokinet. 44, 721\u2013729 (2005).","journal-title":"Clin. Pharmacokinet."},{"key":"125_CR48","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1007\/s00125-011-2340-0","volume":"55","author":"S Larsen","year":"2012","unstructured":"Larsen, S. et al. Metformin-treated patients with type 2 diabetes have normal mitochondrial complex I respiration. Diabetologia 55, 443\u2013449 (2012).","journal-title":"Diabetologia"},{"key":"125_CR49","doi-asserted-by":"publisher","first-page":"538","DOI":"10.5604\/01.3001.0010.0284","volume":"16","author":"A Said","year":"2017","unstructured":"Said, A. & Akhter, A. Meta-analysis of randomized controlled trials of pharmacologic agents in non-alcoholic steatohepatitis. Ann. Hepatol. 16, 538\u2013547 (2017).","journal-title":"Ann. Hepatol."},{"key":"125_CR50","doi-asserted-by":"publisher","first-page":"e4529","DOI":"10.1097\/MD.0000000000004529","volume":"95","author":"R Sawangjit","year":"2016","unstructured":"Sawangjit, R. et al. Comparative efficacy of interventions on nonalcoholic fatty liver disease (NAFLD): a PRISMA-compliant systematic review and network meta-analysis. Med. (Baltim.) 95, e4529 (2016).","journal-title":"Med. (Baltim.)"},{"key":"125_CR51","doi-asserted-by":"publisher","first-page":"576","DOI":"10.1016\/j.cmet.2017.08.011","volume":"26","author":"CW Kim","year":"2017","unstructured":"Kim, C. W. et al. Acetyl CoA carboxylase inhibition reduces hepatic steatosis but elevates plasma triglycerides in mice and humans: a bedside to bench investigation. Cell Metab. 26, 576 (2017).","journal-title":"Cell Metab."},{"key":"125_CR52","doi-asserted-by":"publisher","first-page":"1394","DOI":"10.1016\/j.celrep.2016.04.024","volume":"15","author":"AR Konopka","year":"2016","unstructured":"Konopka, A. R. et al. Hyperglucagonemia mitigates the effect of metformin on glucose production in prediabetes. Cell Rep. 15, 1394\u20131400 (2016).","journal-title":"Cell Rep."},{"key":"125_CR53","doi-asserted-by":"publisher","first-page":"3544","DOI":"10.2337\/db16-0804","volume":"65","author":"AJ Lewis","year":"2016","unstructured":"Lewis, A. J.et al. Assessment of metformin-induced changes in cardiac and hepatic redox state using hyperpolarized [1-13C] pyruvate. Diabetes 65, 3544\u20133551 (2016).","journal-title":"Diabetes"},{"key":"125_CR54","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1007\/s00125-017-4445-6","volume":"61","author":"H Qi","year":"2018","unstructured":"Qi, H. et al. Acute renal metabolic effect of metformin assessed with hyperpolarised MRI in rats. Diabetologia 61, 445\u2013454 (2018).","journal-title":"Diabetologia"},{"key":"125_CR55","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1007\/BF00745143","volume":"13","author":"M Nattrass","year":"1977","unstructured":"Nattrass, M., Todd, P. G., Hinks, L., Lloyd, B. & Alberti, K. G. Comparative effects of phenformin, metformin and glibenclamide on metabolic rhythms in maturity-onset diabetics. Diabetologia 13, 145\u2013152 (1977).","journal-title":"Diabetologia"},{"key":"125_CR56","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1186\/2050-6511-14-25","volume":"14","author":"EK Hussey","year":"2013","unstructured":"Hussey, E. K. et al. Safety, pharmacokinetics and pharmacodynamics of remogliflozin etabonate, a novel SGLT2 inhibitor, and metformin when co-administered in subjects with type 2 diabetes mellitus. BMC Pharmacol. Toxicol. 14, 25 (2013).","journal-title":"BMC Pharmacol. Toxicol."},{"key":"125_CR57","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1016\/0026-0495(90)90044-D","volume":"39","author":"B Comte","year":"1990","unstructured":"Comte, B., Vidal, H., Laville, M. & Riou, J. P. Influence of thyroid hormones on gluconeogenesis from glycerol in rat hepatocytes: a dose-response study. Metabolism 39, 259\u2013263 (1990).","journal-title":"Metabolism"},{"key":"125_CR58","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1016\/0167-4889(92)90096-T","volume":"1137","author":"RB Gregory","year":"1992","unstructured":"Gregory, R. B., Phillips, J. W. & Berry, M. N. Reducing-equivalent transfer to the mitochondria during gluconeogenesis and ureogenesis in hepatocytes from rats of different thyroid status. Biochim. Biophys. Acta 1137, 34\u201338 (1992).","journal-title":"Biochim. Biophys. Acta"},{"key":"125_CR59","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1006\/abbi.1999.1668","volume":"375","author":"N Kneer","year":"2000","unstructured":"Kneer, N. & Lardy, H. Thyroid hormone and dehydroepiandrosterone permit gluconeogenic hormone responses in hepatocytes. Arch. Biochem. Biophys. 375, 145\u2013153 (2000).","journal-title":"Arch. Biochem. Biophys."},{"key":"125_CR60","doi-asserted-by":"crossref","first-page":"1","DOI":"10.33549\/physiolres.932600","volume":"63","author":"Z Drahota","year":"2014","unstructured":"Drahota, Z. et al. Biguanides inhibit complex I, II and IV of rat liver mitochondria and modify their functional properties. Physiol. Res. 63, 1\u201311 (2014).","journal-title":"Physiol. Res."},{"key":"125_CR61","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1007\/s001250051121","volume":"42","author":"MJ Reed","year":"1999","unstructured":"Reed, M. J. et al. Effect of masoprocol on carbohydrate and lipid metabolism in a rat model of type II diabetes. Diabetologia 42, 102\u2013106 (1999).","journal-title":"Diabetologia"},{"key":"125_CR62","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-017-01143-w","volume":"8","author":"RJ Perry","year":"2017","unstructured":"Perry, R. J. et al. Non-invasive assessment of hepatic mitochondrial metabolism by positional isotopomer NMR tracer analysis (PINTA). Nat. Commun. 8, 798 (2017).","journal-title":"Nat. Commun."},{"key":"125_CR63","doi-asserted-by":"publisher","first-page":"740","DOI":"10.1016\/j.cmet.2013.10.004","volume":"18","author":"RJ Perry","year":"2013","unstructured":"Perry, R. J. et al. Reversal of hypertriglyceridemia, fatty liver disease, and insulin resistance by a liver-targeted mitochondrial uncoupler. Cell Metab. 18, 740\u2013748 (2013).","journal-title":"Cell Metab."},{"key":"125_CR64","doi-asserted-by":"publisher","first-page":"1175","DOI":"10.1002\/hep.24170","volume":"53","author":"TC Alves","year":"2011","unstructured":"Alves, T. C. et al. Regulation of hepatic fat and glucose oxidation in rats with lipid-induced hepatic insulin resistance. Hepatology 53, 1175\u20131181 (2011).","journal-title":"Hepatology"},{"key":"125_CR65","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1172\/JCI88477","volume":"127","author":"RJ Perry","year":"2017","unstructured":"Perry, R. J. et al. Mechanism for leptin\u2019s acute insulin-independent effect to reverse diabetic ketoacidosis. J. Clin. Invest. 127, 657\u2013669 (2017).","journal-title":"J. Clin. Invest."},{"key":"125_CR66","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1242\/dmm.006239","volume":"3","author":"JE Ayala","year":"2010","unstructured":"Ayala, J. E. et al. Standard operating procedures for describing and performing metabolic tests of glucose homeostasis in mice. Dis. Model. Mech. 3, 525\u2013534 (2010).","journal-title":"Dis. Model. Mech."},{"key":"125_CR67","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1016\/0003-2697(74)90248-6","volume":"60","author":"JV Passonneau","year":"1974","unstructured":"Passonneau, J. V. & Lauderdale, V. R. A comparison of three methods of glycogen measurement in tissues. Anal. Biochem. 60, 405\u2013412 (1974).","journal-title":"Anal. Biochem."},{"key":"125_CR68","doi-asserted-by":"publisher","first-page":"911","DOI":"10.1139\/y59-099","volume":"37","author":"EG Bligh","year":"1959","unstructured":"Bligh, E. G. & Dyer, W. J. A rapid method of total lipid extraction and purification. Can. J. Biochem. Physiol. 37, 911\u2013917 (1959).","journal-title":"Can. J. Biochem. Physiol."}],"updated-by":[{"DOI":"10.1038\/s41591-018-0220-6","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2019,2,7]],"date-time":"2019-02-07T00:00:00Z","timestamp":1549497600000}}],"container-title":["Nature Medicine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/s41591-018-0125-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/s41591-018-0125-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/s41591-018-0125-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,20]],"date-time":"2023-05-20T17:56:49Z","timestamp":1684605409000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41591-018-0125-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,7,23]]},"references-count":68,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2018,9]]}},"alternative-id":["125"],"URL":"https:\/\/doi.org\/10.1038\/s41591-018-0125-4","relation":{},"ISSN":["1078-8956","1546-170X"],"issn-type":[{"value":"1078-8956","type":"print"},{"value":"1546-170X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,7,23]]},"assertion":[{"value":"29 September 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 June 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 July 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 February 2019","order":4,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Correction","order":5,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"In the version of this article originally published, the V<sub>PC<\/sub> and V<sub>CS<\/sub> flux data shown in Fig. 6e,f were inadvertently duplicated from Fig. 5j,k. The correct data are now shown in Fig. 6e,f. In these corrected data, V<sub>PC<\/sub> flux in response to chronic oral metformin treatment was still significantly decreased (Fig. 6e), and there was still no impact of metformin on V<sub>CS<\/sub> flux (Fig. 6f). Therefore, the text describing these data remains the same and this correction does not change the conclusion of this study.","order":6,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}